Avancier Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in Indianapolis, IN and active since 2010.
Avancier Pharmaceuticals LLC was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact James R Mccarthy at the company’s single location by writing to 351 West 10th St # 222, Indianapolis, Indiana IN 46202 or by phoning (317) 274-3642. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Avancier Pharmaceuticals LLC |
| Contact Person: | James R Mccarthy |
| Address: | 351 West 10th St # 222, Indianapolis, Indiana 46202 |
| Phone Number: | (317) 274-3642 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Avancier Pharmaceuticals LLC was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact James R Mccarthy for inquiries that concern Avancier Pharmaceuticals LLC by calling the company number (317) 274-3642, as your correspondence is most welcome. Additionally, the physical location of the single location of Avancier Pharmaceuticals LLC can be found at the coordinates 39.780863,-86.164949 as well as the street address 351 West 10th St # 222 in Indianapolis, Indiana 46202.
For its online presence, you may visit Avancier Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.